AMBQMEDIUM SIGNALFINANCIAL10-Q

AMBQ demonstrated strong quarterly revenue growth and a substantial improvement in cash position, though operating losses widened and the company continues to burn cash.

The company appears to be in a growth phase with revenue expanding meaningfully and cash resources strengthening significantly, likely from equity funding activities. However, the widening operating losses and continued cash flow deficits indicate AMBQ remains in the investment phase and has not yet achieved operational profitability.

Comparing 2025-11-06 vs 2025-09-04View on EDGAR →
FINANCIAL ANALYSIS

The quarter showed robust top-line growth with revenue expanding 38% and gross profit growing 41.9%, while R&D expenses increased 44.4% reflecting continued investment in development. The balance sheet strengthened considerably with cash rising 45.8% to over $200M and stockholders' equity growing 44.7%, suggesting successful capital raising activities. Despite revenue gains, operating losses widened as the company continues prioritizing growth investments over near-term profitability.

FINANCIAL STATEMENT CHANGES
Accounts Receivable
Balance Sheet
+50.6%
$7.3M→$11.0M

Receivables surged 50.6% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Cash & Equivalents
Balance Sheet
+45.8%
$140.3M→$204.5M

Cash position surged 45.8% — strong cash generation or capital raise providing significant financial cushion.

Stockholders Equity
Balance Sheet
+44.7%
$162.5M→$235.2M

Equity base grew 44.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.

R&D Expense
P&L
+44.4%
$8.9M→$12.8M

R&D investment increased 44.4% — signals commitment to future product development, though near-term margin impact.

Current Assets
Balance Sheet
+43.9%
$167.9M→$241.7M

Current assets grew 43.9% — improving short-term liquidity or inventory/receivables build.

Gross Profit
P&L
+41.9%
$7.7M→$10.9M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Total Assets
Balance Sheet
+40.5%
$184.7M→$259.5M

Asset base grew 40.5% — expansion through organic growth, acquisitions, or capital deployment.

Inventory
Balance Sheet
+38.5%
$16.9M→$23.5M

Inventory surged 38.5% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

Revenue
P&L
+38%
$18.2M→$25.1M

Strong top-line growth of 38% — accelerating demand or successful expansion into new markets.

Operating Income
P&L
-16.4%
-$10.0M→-$11.7M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

LANGUAGE CHANGES
NEW — 2025-11-06
PRIOR — 2025-09-04
ADDED
Financial Statements (Unaudited) 2 Condensed Consolidated Balance Sheets 2 Condensed Consolidated Statements of Operations and Comprehensive Loss 3 Consolidated Statements of Changes in Stockholders Equity (Deficit) 4 Condensed Consolidated Statements of Cash Flows 5 Notes to Unaudited Condensed Consolidated Financial Statements 6 Item 2.
Liquidity and Capital Resources During the three months ended September 30, 2025, the Company reported a net loss of $ 9.0 million.
During the nine months ended September 30, 2025, the Company reported a net loss of $ 25.8 million and had an operating cash flow deficit of $ 15.6 million.
As of September 30, 2025, the Company had cash and cash equivalents totaling $ 146.5 million.
Si nce inception, the Company has had negative cash flows and losses from operations which it has funded primarily through cash from operations and equity issuances.
The failure to raise funds as and when needed and generate adequate sales could have a negative impact on the Company s financial condition .
Initial Public Offering On July 18, 2025, the Company effected a 1-for-28 reverse stock split (the Stock Split) of the Company s issued and outstanding shares of common stock and options to purchase common stock.
On July 31, 2025, the Company completed its IPO, in which 4,600,000 shares of common stock, par value $ 0.000001 per share, were issued and sold, inclusive of the exercise in full of the underwriters' option to purchase 600,000 additional shares.
Upon consummation of the IPO, $ 2.8 million of such costs were recorded as a reduction of the proceeds generated from the offering, which was recognized in additional paid-in capital.
Demand The Company had three customers representing 38 % , 26 % and 11 % , respectively, of total accounts receivable as of September 30, 2025.
REMOVED
Financial Statements (Unaudited) 2 Condensed Consolidated Balance Sheets 2 Condensed Consolidated Statements of Comprehensive Income (Loss) 3 Consolidated statements of changes in redeemable convertible preferred stock and stockholders deficit 4 Condensed Consolidated Statements of Cash Flows 5 Notes to Unaudited Condensed Consolidated Financial Statements 6 Item 2.
Liquidity and Capital Resources During the three months ended June 30, 2025, the Company reported a net loss of $ 8.5 million.
During the six months ended June 30, 2025, the Company reported a net loss of $ 16.8 million and had an operating cash flow deficit of $ 10.5 million.
As of June 30, 2025, the Company had cash and cash equivalents totaling $ 47.5 million.
Since inception, the Company has had negative cash flows and losses from operations which it has funded primarily through the issuances of common and preferred stock.
The failure to raise funds as and when needed and generate adequate sales could have a negative impact on the Company s financial condition and ability to satisfy its obligations over the next twelve month s.
Deferred Offering Costs Deferred offering costs consist primarily of accounting, legal and other fees related to the IPO.
As of June 30, 2025 , $ 1.1 million of deferred offering costs were included within prepaid and other current assets in the condensed consolidated balance sheets.
Demand The Company had three customers representing 41 % , 40 % and 15 % , respectively, of total accounts receivable as of June 30, 2025.
The Company had three customers representing 30 % , 29 % and 19 % , respectively, of total accounts receivable as of June 30, 2024, one of which was the same customer as of June 30, 2025.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →